GOLDMAN SACHS GROUP INC - LARIMAR THERAPEUTICS INC ownership

LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 49 filers reported holding LARIMAR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of LARIMAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$535,624
+26.7%
135,601
+0.4%
0.00%
Q2 2023$422,854
-47.2%
135,097
-23.6%
0.00%
Q1 2023$801,271
+72.2%
176,881
+57.0%
0.00%
Q4 2022$465,393
+138.7%
112,686
+84.9%
0.00%
Q3 2022$195,000
+29.1%
60,930
+366.8%
0.00%
Q3 2021$151,000
+7.1%
13,053
-8.8%
0.00%
Q2 2021$141,00014,3140.00%
Other shareholders
LARIMAR THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 1,515,148$14,879,0003.46%
Opaleye Management Inc. 727,800$7,147,0001.19%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,830,249$57,253,0001.02%
Fi3 FINANCIAL ADVISORS, LLC 121,818$1,218,0000.84%
Vivo Capital, LLC 799,662$7,853,0000.34%
Atlas Venture Advisors, Inc. 292,184$2,869,0000.30%
Ghost Tree Capital, LLC 100,000$982,0000.27%
RA Capital Management 1,515,151$14,879,0000.24%
DAFNA Capital Management LLC 76,987$756,0000.16%
683 Capital Management, LLC 256,620$2,520,0000.09%
View complete list of LARIMAR THERAPEUTICS INC shareholders